Cold Pain Therapy Market Report 2026

The cold pain therapy market size has grown strongly in recent years. It will grow from $1.87 billion in 2025 to $2.01 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to growing incidence of musculoskeletal injuries, expansion of sports medicine practices, increased use of cold packs in acute care, rising adoption of otc pain relief products, wider availability of cryotherapy devices.

The cold pain therapy market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for home-based pain management, rising focus on drug-free therapy options, expansion of sports and fitness activities, growing adoption of wearable cold therapy devices, increasing integration of cold therapy in rehabilitation protocols. Major trends in the forecast period include increasing use of advanced cryotherapy devices, rising demand for non-invasive pain management solutions, growing adoption of portable cold therapy products, expansion of sports injury treatment applications, enhanced focus on post-surgical recovery support.

The increasing number of road accidents is expected to support the growth of the cold pain therapy market in the coming years. Road accidents are incidents that occur on roads and involve vehicles such as cars, motorcycles, bicycles, pedestrians, and other forms of transportation. The rising incidence of road accidents globally is expanding the demand for cold pain therapy products, as they provide a non-invasive and easily accessible option for pain relief and recovery support following injuries. For example, in October 2025, according to a report published by the National Highway Traffic Safety Administration, a US-based national safety organization, the United States recorded 6,138,359 police-reported motor vehicle crashes, resulting in 40,901 fatalities and 2,442,581 injuries, underscoring the substantial burden of trauma. As a result, the growing number of road accidents is driving the cold pain therapy market.

Major companies operating in the cold pain therapy market are increasingly engaging in strategic partnerships and collaborations with start-ups and mid-sized firms to expand their product offerings and service portfolios. Strategic collaborations and partnership agreements enable companies to strengthen their existing product range and extend their geographic presence. For instance, in August 2023, Breg, a US-based orthopedic bracing and billing services company, announced a new international partnership with Amos Gazit Ltd., an Israel-based provider of products and services for the safety and medical industries. This collaboration is intended to strengthen Breg’s footprint in the Israeli market by supplying high-quality orthopedic bracing and cold therapy products to healthcare providers and patients. The partnership supports Breg’s broader strategy of enhancing distribution capabilities and improving access to orthopedic solutions that often incorporate cold therapy to improve pain management outcomes.

In October 2025, Celltrion Healthcare Co. Ltd., a South Korea-based biopharmaceutical company, partnered with Wellscare Co. Ltd. to introduce advanced wearable pain relief technology in North America. Through this partnership, Celltrion Healthcare Co. Ltd. and Wellscare Co. Ltd. aim to expand access to innovative, drug-free pain management solutions by combining Celltrion’s commercial distribution strength with Wellscare’s IASO microcurrent therapy device. This collaboration seeks to deliver more effective, convenient, and technology-driven pain relief options for consumers across the region. Wellscare Co. Ltd. is a South Korea-based medical technology company specializing in the development of wearable microcurrent devices for non-invasive pain management.

Major companies operating in the cold pain therapy market are Össur Corporate, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Rohto Pharmaceutical Co. Ltd., 3M Company, Cardinal Health Inc., Compass Health Brands, Breg Inc., Medline Industries LP, Performance Health Supply Inc., Beiersdorf AG, DJO Global Inc., Polar Products Inc., Mueller Sports Medicine Inc., Bruder Healthcare Company LLC, ThermoTek Inc., Performance Health LLC, Unexo Lifesciences Pvt. Ltd., Romsons Group of Industries, Boehringer Ingelheim International GmbH.

North America was the largest region in the cold pain therapy market share in 2025. The regions covered in the cold pain therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cold pain therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the cold pain therapy market by increasing costs of imported cooling systems, electronic components, medical-grade plastics, and specialized packaging materials. Healthcare providers and sports medicine facilities in North America and Europe are most affected due to reliance on imported therapeutic devices, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising product prices and affecting procurement decisions. However, they are also encouraging domestic manufacturing, localized sourcing of materials, and innovation in cost-effective cold therapy solutions.

The cold pain therapy market research report is one of a series of new reports that provides cold pain therapy market statistics, including cold pain therapy industry global market size, regional shares, competitors with a cold pain therapy market share, detailed cold pain therapy market segments, market trends and opportunities, and any further data you may need to thrive in the cold pain therapy industry. This cold pain therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cold pain therapy is a treatment approach used to effectively reduce inflammation and swelling. Its primary purpose is to manage injuries that cause pain by lowering the temperature at the surface of the affected area. This therapy helps slow the rate of tissue damage around joints or tendons.

The main products used in cold pain therapy include over-the-counter (OTC) and prescription products. OTC cold pain therapy products are designed to reduce inflammation and swelling that lead to pain by decreasing the temperature around the affected area. Over-the-counter cold pain therapy products can be purchased without a prescription and are considered safe and effective when used according to label instructions. These products are distributed through retail pharmacies, hospital pharmacies, and e-pharmacies, and are commonly used for the treatment of musculoskeletal disorders, post-operative therapy, sports injuries, and post-trauma therapy.

The cold pain therapy market consists of sales of gels, ointments, creams, and foams. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.